Drug information for ABLAVAR
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
SOLUTION; INTRAVENOUS
2440MG/10ML (244MG/ML)
Prescription
GADOFOSVESET TRISODIUM
gadofosveset trisodium
LANTHEUS MEDCL
21711
2011-12-21 Other Important Information from FDA
2010-12-22 Letter
2010-12-20 Label
2010-01-29 Label
2010-01-15 Letter
2009-04-02 Summary Review
2009-03-31 Review
2009-01-02 Letter
SOLUTION; INTRAVENOUS
3660MG/15ML (244MG/ML)
Prescription
(Reference Drug)
GADOFOSVESET TRISODIUM
gadofosveset trisodium
LANTHEUS MEDCL
"
Drug Adverse Effects information for ABLAVAR
Role code
Indications
Reaction
# Reports
PS
NUCLEAR MAGNETIC RESONANCE IMAGING
NAUSEA
1
PS
NUCLEAR MAGNETIC RESONANCE IMAGING
SYNCOPE
1
PS
NUCLEAR MAGNETIC RESONANCE IMAGING
VOMITING
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
BUDD-CHIARI SYNDROME
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
NAUSEA
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
POST PROCEDURAL COMPLICATION
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
SYNCOPE
1
PS
PRODUCT USED FOR UNKNOWN INDICATION
VOMITING
1
PS
RENAL ANEURYSM
NAUSEA
1
PS
RENAL ANEURYSM
SYNCOPE
1
PS
RENAL ANEURYSM
VOMITING
1
Ads by Google